Check out our participation in the launch of #ComunidadDesafia! ?

We’re excited to be part of this dynamic community and look forward to the opportunities and collaborations ahead.

hashtag#YosoyDesafia
hashtag#ICEX

We had the privilege of attending the EMEA Summit as part of the JLabs family. ?✨

Johnson & Johnson Innovation – JLABS is a global life science network offering startups like ours access to expertise, a vibrant community, essential industry connections, and comprehensive entrepreneurial programs.

Being a part of this dynamic network accelerates our mission and amplifies our impact in the life sciences sector.??

Yesterday, we had an inspiring partner meeting at TETRANEURON , reaffirming our commitment to pioneering innovative gene therapies for neurodegenerative diseases. We extend our gratitude to our partners for their ongoing support. Together, we are making a difference!? #GeneTherapy #NeurodegenerativeDiseases #Innovation#Tetraneuron

? Exciting News! ? We’re thrilled to announce that we’ll be attending the RESI Europe conference in Barcelona on June 19th! Our team is excited to present our innovative project to international investors. Let’s connect and explore opportunities at RESI Europe. See you in Barcelona! ? #RESIEurope #Barcelona #Innovation #Investment #Networking

https://www.linkedin.com/posts/tetraneuron_tetraneuron-genetherapy-activity-7183463740216885248-vUp3

Embracing Change in 2024: We’re giving our website a fresh new look! Join us on this exciting journey to stay in the loop with all things Tetraneuron. Don’t miss out on the latest from Tetraneuron ? https://tetraneuron.com #TetraneuronUpdates #genetherapy

Fascinating piece by Expansión discussing the power of patents in companies like TETRANEURON . We’re all about robust IP for every innovation we craft? Thank you, Alive comunicación! ? #patents #genetherapy

We were delighted to have the opportunity to speak at #Biozell‘s #InvestorDay. Such events are pivotal in highlighting the innovation within the Spanish biotech sector. It was a pleasure to share the stage with other remarkable projects! #bioval #tetraneuron #alzheimer #genetherapy

Excited to welcome amazing investors like Biozell! ? Mark your calendar for October 17th. During the Investor’s Day, they will present their ongoing ventures and brand-new investment possibilities. We’re thrilled to showcase our project at this event. Don’t miss this opportunity to join it! #investment #alzheimer #genetherapy

Great day at #BioRNConference, Next-Generation Cell and Gene Therapies. #genetherapy #alzheimer

Meet us at #BIOSPAIN2023 in Barcelona ! Just a few days left to interact with experts, companies and investors from all over the world. Find our colleagues Maria del Mar Municio, Ph.D and M.Carmen Alvarez Abril at the partnering area. See you there! #Alzheimer #genetherapy

Exciting News! Join us at #IBRO2023 Conference. Our colleagues Cristina Sánchez-Puelles, PhD and Morgan Ramón Landreau will be presenting our amazing research on Alzheimer’s Disease. Visit us! ?Poster B28 ?Poster B03 #genetherapy #Tetraneuron #alzheimer

Great news! Congratulations to Maria del Mar Municio, Ph.D for her incorporation as R&D Director at TETRANEURON .Undoubtedly, her experience and leadership will further drive the innovation and development of the company. #Tetraneuron #Innovation #Leadership #alzheimer #genetherapy

Delighted by the industry’s progress! ? Yet, Alzheimer’s Drug Discovery Foundation reminds us to explore diverse pathways for more effective treatments. Our promising therapy targets key areas to make a difference. #Alzheimers #genetherapy #Tetraneuron

Muchas gracias #Valenciaplaza por haceros eco de esta importante noticia para #Tetraneuron Estamos encantados de contar con #Biozellventures como nuevo socio y contar con el enorme talento y experiencia de Angela Perez y su equipo. ¡Seguimos! ????? #genetherapy #alzheimersdisease #advancedtherapies #parkinson #biotech

Muchas gracias #Mendelbrain por haceros eco de esta importante noticia para #Tetraneuron ¡Seguimos! #terapiagenica #genetherapy #cns #snc #alzheimers #parkinson #aging #innovation #biotech #advancedtherapies

A new day in #AAIC23

Great news!? Biozell Ventures, the investment arm of BIOHUB VLC, is betting on Tetraneuron’s new gene therapy for Alzheimer’s disease. Please join us in welcoming our newest investors to the Tetraneuron family! #alzheimer #genetherapy

A new day in #AAIC2023!

The Alzheimer’s Association®International Conference (AAIC)- the most relevant conference on #alzheimer– starts next Sunday, 16 July, in Amsterdam! The Tetraneuron team is looking forward to joining researchers and clinicians to discuss the latest advances in the field. Several team members will present a poster during the event! – José María Frade. Scientific Director – Cristina Sánchez-Puelles, PhD. Senior Researcher – Morgan Ramón Landreau. Researcher Visit our posters or meet the team to learn more about our therapy TET-101. See you in #AAIC2023! #Tetraneuron #alzheimer #genetherapy